VivoSeq
Oncology

Unresectable Colorectal Liver Metastases

0

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

Unresectable Colorectal Liver Metastases is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Recruiting2 · 50%
Not yet recruiting1 · 25%
Completed1 · 25%

Clinical Trials

Trial Activity

Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 1·NCT04062721·12 enrolled
Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy
Recruiting·TThe Netherlands Cancer Institute·Phase 3·NCT06857773·306 enrolled
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
Completed·—·Phase 1·NCT00557557·14 enrolled
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Recruiting·ECOG-ACRIN Cancer Research Group·Phase 3·NCT05863195·408 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)